Disclosure 0001193125-26-397936-1

SEC FORM 4

$74,464.00

Atrium Therapeutics, Inc. (RNA)

Disposition (code F) of 8,320 shares at $8.95 per share.

Reporting Person Hoyos Rocio Martin · Officer Title Chief Strategy Officer · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-397936 · filed 2026-09-22 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Atrium Therapeutics, Inc. (RNA)." Disclosed 2026-09-22. https://desqlong.com/cards/0001193125-26-397936-1 (retrieved 2026-09-26).